| Literature DB >> 28830437 |
James Wabwire Oguttu1, Daniel Nenene Qekwana2, Agricola Odoi3,4.
Abstract
BACKGROUND: Antimicrobial resistant Staphylococcus are becoming increasingly important in horses because of the zoonotic nature of the pathogens and the associated risks to caregivers and owners. Knowledge of the burden and their antimicrobial resistance patterns are important to inform control strategies. This study is an exploratory descriptive investigation of the burden and antimicrobial drug resistance patterns of Staphylococcus isolates from horses presented at a veterinary teaching hospital in South Africa.Entities:
Keywords: Antimicrobial resistance; Gauteng; Horse; MDR; Multi-drug resistance; South Africa; Staphylococcus aureus; Staphylococcus chromogens; Staphylococcus epidermidis; Staphylococcus pseudintemedius
Mesh:
Substances:
Year: 2017 PMID: 28830437 PMCID: PMC5568347 DOI: 10.1186/s12917-017-1196-z
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Host factor distribution of equine samples from Gauteng Province (South Africa) tested for Staphylococcus, 2007–2012
| All Samples Processed | Staphylococcus Positive Samples | |||||
|---|---|---|---|---|---|---|
| Breed | na | %b | 95% CIc | na | %b | 95% CIc |
| American Saddler | 39 | 3.8 | 2.8, 5.2 | 4 | 10.3 | 3.8, 24.6 |
| Arab | 119 | 11.6 | 9.8, 13.7 | 8 | 6.7 | 3.4, 12.9 |
| Boerperd | 37 | 3.6 | 2.6, 4.9 | 7 | 18.9 | 9.2, 35.0 |
| Crossbreed | 39 | 3.8 | 2.8, 5.2 | 8 | 20.5 | 10.5, 36.2 |
| European warm blood | 129 | 12.6 | 10.7, 14.7 | 23 | 17.8 | 12.1, 25.4 |
| Friesian | 62 | 6.0 | 4.7, 7.7 | 2 | 3.2 | 0.8, 12.1 |
| Nooitgedachtpony | 43 | 4.2 | 3.1, 5.6 | 5 | 11.6 | 4.9, 25.3 |
| South African warm blood | 66 | 6.4 | 5.1, 8.1 | 1 | 1.5 | 0.2, 10.1 |
| Thoroughbred | 275 | 26.8 | 24.2, 29.6 | 21 | 7.6 | 5.0, 11.4 |
| Welshpony | 25 | 2.4 | 1.6, 3.6 | 3 | 12.0 | 3.8, 31.9 |
| Percheron | 13 | 1.3 | 0.7, 2.2 | 0 | 0 | - |
| All other breeds | 73 | 7.1 | 5.6, 8.9 | 6 | 8.2 | 3.1, 17.1 |
| Unspecified or missing | 107 | 10.4 | 8.7, 12.4 | 35 | 32.7 | 24.0, 42.5 |
| Age Group | ||||||
| Foal (< 1 year) | 278 | 27.1 | 24.4, 29.9 | 58 | 20.9 | 16.2, 26.1 |
| Yearling (1–2 years) | 83 | 8.1 | 6.5, 9.9 | 9 | 10.8 | 5.1, 19.6 |
| Filly or Colt (2–4 years) | 146 | 14.2 | 12.1, 16.5 | 13 | 8.9 | 4.8, 14.7 |
| Adult (> 4 years) | 520 | 50.6 | 47.5, 53.7 | 43 | 8.3 | 6.0, 11.0 |
| Sex | ||||||
| Males | 499 | 48.6 | 45.5, 51.7 | 48 | 9.6 | 7.2, 12.6 |
| Females | 434 | 42.2 | 39.2, 45.3 | 44 | 10.1 | 7.6, 13.4 |
| Unspecified or missing | 94 | 9.2 | 7.5, 11.1 | 31 | 33.0 | 23.6, 43.4 |
anumber of samples
bpercentage of samples
c95% confidence interval
Temporal and Geographic distribution of equine samples from Gauteng Province assessed for antimicrobial susceptibility, 2007–2012
| All Samples Processed ( |
| AMRc Isolates ( | MDRd
| |||||
|---|---|---|---|---|---|---|---|---|
| %b | 95% CIa | % | 95% CIa | % | 95% CIa | % | 95% CIa | |
| Season | ||||||||
| Summer | 40.8 | 37.8, 43.8 | 10.0 | 7.4, 13.3 | 64.3 | 48.6, 77.4 | 38.1 | 24.6, 53.8 |
| Autumn | 18.6 | 16.3, 21.1 | 14.1 | 9.9, 19.9 | 29.6 | 15.2, 49.6 | 14.8 | 5.5, 34.2 |
| Winter | 25.0 | 22.5, 27.8 | 12.1 | 8.6, 16.7 | 58.1 | 40.0, 74.2 | 41.9 | 25.8, 60.0 |
| Spring | 15.6 | 13.5, 17.9 | 14.4 | 9.7, 20.7 | 47.8 | 28.3, 68.1 | 8.7 | 2.1, 29.9 |
| Year | ||||||||
| 2007 | 34.1 | 31.2, 37.0 | 7.7 | 5.3, 11.0 | 55.6 | 36.4, 73.2 | 14.8 | 5.5, 34.2 |
| 2008 | 15.5 | 13.4, 17.8 | 8.2 | 4.8, 13.6 | 53.8 | 27.0, 78.6 | 15.4 | 3.6, 47.0 |
| 2009 | 16.1 | 13.9, 18.4 | 12.1 | 7.9, 18.1 | 55.0 | 32.9, 75.3 | 35.0 | 17.2, 58.3 |
| 2010 | 8.8 | 7.2, 10.7 | 13.3 | 7.7., 22.1 | 33.3 | 12.4, 63.9 | 8.3 | 1.0, 44.1 |
| 2011 | 7.1 | 5.7, 8.9 | 6.8 | 2.9, 15.5 | 60.0 | 16.6, 91.9 | 20.0 | 2.1, 74.8 |
| 2012 | 18.5 | 16.2, 21.0 | 24.2 | 18.6, 30.8 | 52.2 | 37.7, 66.3 | 43.5 | 29.8, 58.2 |
| Municipality | ||||||||
| Johannesburg | 20.0 | 17.6, 22.5 | 11.7 | 7.6, 16.9 | 54.2 | 34.0, 73.0 | 33.3 | 17.2, 54.5 |
| Tshwane | 61.2 | 58.2, 64.2 | 11.6 | 9.2, 14.4 | 49.3 | 37.9, 60.8 | 26.0 | 16.5, 37.6 |
| Ekurhuleni | 10.1 | 8.4, 12.1 | 10.6 | 5.4, 18.1 | 63.6 | 32.3, 86.5 | 36.4 | 13.5, 67.7 |
| Sedibeng | 2.4 | 1.6, 3.6 | 20.0 | 6.8, 40.7 | 40.0 | 5.3, 85.3 | 20.0 | 0.5, 71.6 |
| West Rand | 6.2 | 4.9, 7.9 | 10.0 | 7.8, 26.9 | 60.0 | 26.3,87.8 | 30.0 | 6.7, 65.2 |
a95% confidence interval
bPercent
cAMR: Antimicrobial resistant (defined as resistance to at least one antimicrobial)
dMDR: Multidrug resistant (defined as resistance to at least three classes of antimicrobials; includes a subset of AMR isolates)
Distribution of antimicrobial resistance by species of Staphylococcus and antimicrobial agent
| Resistant Isolates | MDR Isolates | |||
|---|---|---|---|---|
| % | 95% CI | % | 95% CI | |
| Species |
|
| ||
|
| 72.5 | 58.3, 83.3a | 52.9 | 38.5, 67.1a |
|
| 38.9 | 19.2, 63.0b | 16.7 | 3.6, 41.4b |
|
| 30.4 | 18.7, 45.4b | 2.2 | 0.1, 11.5c |
| All other species | 75.0 | 34.9, 96.8a | 50.0 | 15.7, 84.3a |
| Antimicrobial & Antimicrobial Class |
|
| ||
| Aminoglycosides3 | ||||
| Gentamycin | 54.6 | 42.1, 66.7a | 48.9 | 38.1, 59.8 |
| Amikacin | 14.1 | 7.3, 25.2e | 9.1 | 4.0, 17.1 |
| Β-lactams4 | ||||
| Ampicillin | 84.5 | 72.3, 91.9b | 37.5 | 27.4, 48.5 |
| Penicillin | 74.1 | 61.0, 84.0b | 37.5 | 27.4, 48.5 |
| Ceftriaxone | 44.8 | 32.3, 58.1c | 30.0 | 20.3, 41.3 |
| Fluoroquinolones5 | ||||
| Enrofloxacin | 23.4 | 14.5, 35.7c | 18.8 | 10.1, 30.5b |
| Folate Pathway Inhibitors6 | ||||
| Trimotherim-sulfamethoxazole | 60.9 | 48.2, 72.3a | 53.1 | 40.2, 65.7a |
| Tetracyclines7 | ||||
| Doxycyline | 46.9 | 34.8, 59.4a,d | 35.9 | 24.3, 48.9c |
| Phenicols | ||||
| Chloramphenicol | 44.1 | 31.7, 57.2d | 31.3 | 20.2, 44.1c |
1Samples that were not identified to species level and were thus reported as Staphylococcus spp.
2Other species included S. equinus, S. chromogens and S. epidermidis
3Gentamycin and amikacin
4Penicillin, ampicillin, ceftriaxone
5Enrofloxacin
6Sulphamethoxazole
7Chloramphenicol
a-dEstimates with different superscripts are significantly different at 5% significance level
Distribution of number of antimicrobial classes to which equine samples exhibited resistance (n = 64)
| Number of antimicrobial classes to which isolates exhibited resistance | Number of isolates | Percent | 95% CIa |
|---|---|---|---|
| 1 | 17 | 26.6 | 16.3, 39.1 |
| 2 | 12 | 18.8 | 10.1, 30.4 |
| 3 | 7 | 10.9 | 4.5, 21.2 |
| 4 | 12 | 18.8 | 10.1, 30.4 |
| 5 | 8 | 12.5 | 5.6, 23.2 |
| 6 | 8 | 12.5 | 5.6, 23.2 |
a95% confidence interval
Antimicrobial resistance patterns of staphylococcal isolates from equine samples from Gauteng Province (South Africa), 2007–2012
| Horse Age | Breed of Horse | Municipality | Year | Staphylococcus Species | Antimicrobial Resistance Patterns a |
|---|---|---|---|---|---|
| 0 | Thoroughbred | Tshwane | 2008 |
| AMP-DOX-PEN |
| 0 | Europeanwarmblood | Mogale City | 2011 |
| AMP-PEN-SUL |
| 132 | Crossbreed | Tshwane | 2007 |
| AMI-AMP-PEN |
| 0 | Boerperd | Tshwane | 2007 |
| AMP-DOX-PEN |
| 0 | Boerperd | Tshwane | 2007 |
| AMP-DOX-PEN |
| 0 | Unpecified or Missing | Tshwane | 2007 |
| AMP-CEF-PEN |
| 131 | Europeanwarmblood | Johannesburg | 2008 |
| AMP-PEN-SUL |
| 48 | Europeanwarmblood | Tshwane | 2012 |
| AMP-GEN-PEN-SUL |
| 182 | Boerperd | Tshwane | 2012 |
| AMP-GEN-PEN-SUL |
| 1 | Arab | Tshwane | 2007 |
| AMP-CEF-PEN-SUL |
| 96 | All other breeds | Tshwane | 2012 |
| DOX-ENR-GEN-SUL |
| 40 | All other breeds | Tshwane | 2007 |
| AMP-CEF-GEN-PEN-SUL |
| 96 | Europeanwarmblood | Tshwane | 2012 |
| DOX-ENR-GEN-PEN-SUL |
| 0 | Unpecified or Missing | Tshwane | 2012 |
| AMP-CEF-CHL-PEN-SUL |
| 83 | Europeanwarmblood | Johannesburg | 2012 |
| AMP-CHL-GEN-PEN-SUL |
| 48 | Europeanwarmblood | Tshwane | 2012 |
| AMP-DOX-GEN-PEN-SUL |
| 84 | Thoroughbred | Tshwane | 2012 |
| AMP-CEF-GEN-PEN-SUL |
| 0 | Europeanwarmblood | Johannesburg | 2008 |
| AMP-CEF-GEN-PEN-SUL |
| 0 | Unpecified or Missing | Tshwane | 2012 |
| AMP-CEF-CHL-GEN-PEN-SUL |
| 0 | Unpecified or Missing | Emfuleni | 2012 |
| AMP-CEF-CHL-GEN-PEN-SUL |
| 0 | Unpecified or Missing | Tshwane | 2012 |
| AMP-CEF-DOX-GEN-PEN-SUL |
| 84 | Thoroughbred | Ekurhuleni | 2007 |
| AMP-CEF-DOX-GEN-PEN-SUL |
| 168 | Europeanwarmblood | Ekurhuleni | 2012 |
| AMP-CEF-CHL-GEN-PEN-SUL |
| 0 | American Saddler | Ekurhuleni | 2007 |
| AMP-CEF-DOX-GEN-PEN-SUL |
| 81 | Thoroughbred | Tshwane | 2009 |
| AMP-CEF-DOX-GEN-PEN-SUL |
| 0 | American Saddler | Ekurhuleni | 2007 |
| AMP-CEF-DOX-GEN-PEN-SUL |
| 48 | Europeanwarmblood | Westonaria | 2012 |
| AMP-CHL-DOX-GEN-PEN-SUL |
| 19 | Europeanwarmblood | Westonaria | 2012 |
| AMP-CHL-DOX-ENR-GEN-PEN-SUL |
| 108 | Thoroughbred | Tshwane | 2009 |
| AMP-CEF-CHL-DOX-GEN-PEN-SUL |
| 0 | Arab | Johannesburg | 2012 |
| AMI-AMP-CHL-DOX-GEN-PEN-SUL |
| 168 | Europeanwarmblood | Johannesburg | 2012 |
| AMP-CEF-CHL-DOX-GEN-PEN-SUL |
| 36 | Europeanwarmblood | Westonaria | 2010 |
| AMP-CEF-CHL-DOX-ENR-GEN-SUL |
| 111 | All other breeds | Tshwane | 2009 |
| AMP-CEF-CHL-DOX-GEN-PEN-SUL |
| 96 | American Saddler | Tshwane | 2012 |
| AMI-AMP-CEF-CHL-GEN-PEN-SUL |
| 0 | Nooitgedachtpony | Tshwane | 2009 |
| AMI-AMP-CEF-CHL-DOX-ENR-GEN-PEN |
| 120 | Europeanwarmblood | Johannesburg | 2009 |
| AMI-AMP-CEF-DOX-ENR-GEN-PEN-SUL |
| 182 | Boerperd | Tshwane | 2012 |
| AMP-CEF-CHL-DOX-ENR-GEN-PEN-SUL |
| 48 | Europeanwarmblood | Tshwane | 2012 |
| AMP-CEF-CHL-DOX-ENR-GEN-PEN-SUL |
| 155 | Thoroughbred | Johannesburg | 2012 |
| AMI-AMP-CHL-DOX-ENR-GEN-PEN-SUL |
| 83 | Thoroughbred | Johannesburg | 2011 |
| AMI-AMP-CEF-CHL-DOX-ENR-GEN-PEN-SUL |
| 0 | Unpecified or Missing | Tshwane | 2009 |
| AMI-AMP-CEF-CHL-DOX-ENR-GEN-PEN-SUL |
| 72 | Thoroughbred | Tshwane | 2009 |
| AMI-AMP-CEF-CHL-DOX-ENR-GEN-PEN-SUL |
aAMI = Amikacin; AMP = Ampicillin; CEF = Ceftriaxone; CHL = Chloramphenicol; DOX = Doxycycline; ENR = Enrofloxacin; GEN = Gentamicin; PEN = Penicillin; SUL = Sulphametho